136 related articles for article (PubMed ID: 23867391)
41. Evaluation of different markers in non-small cell lung cancer: prognostic value of clinical staging, tumour cell detection and tumour marker analysis for tumour progression and overall survival.
Kasimir-Bauer S; Schleucher N; Weber R; Neumann R; Seeber S
Oncol Rep; 2003; 10(2):475-82. PubMed ID: 12579292
[TBL] [Abstract][Full Text] [Related]
42. Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer.
Kim JH; Bogner PN; Ramnath N; Park Y; Yu J; Park YM
Clin Cancer Res; 2007 Jul; 13(13):3875-82. PubMed ID: 17606720
[TBL] [Abstract][Full Text] [Related]
43. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
[TBL] [Abstract][Full Text] [Related]
44. AP‑4 predicts poor prognosis in non‑small cell lung cancer.
Gong H; Han S; Yao H; Zhao H; Wang Y
Mol Med Rep; 2014 Jul; 10(1):336-40. PubMed ID: 24804973
[TBL] [Abstract][Full Text] [Related]
45. Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer.
Pei BX; Sun BS; Zhang ZF; Wang AL; Ren P
J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1208-1216.e2. PubMed ID: 24907005
[TBL] [Abstract][Full Text] [Related]
46. High-level expression of Hsp90β is associated with poor survival in resectable non-small-cell lung cancer patients.
Kim SH; Ji JH; Park KT; Lee JH; Kang KW; Park JH; Hwang SW; Lee EH; Cho YJ; Jeong YY; Kim HC; Lee JD; Jang I; Lee JS; Lee HW; Lee GW
Histopathology; 2015 Oct; 67(4):509-19. PubMed ID: 25704653
[TBL] [Abstract][Full Text] [Related]
47. Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
Zenke Y; Ishii G; Ohe Y; Kaseda K; Yoshida T; Matsumoto S; Umemura S; Yoh K; Niho S; Goto K; Ohmatsu H; Kuwata T; Nagai K; Ochiai A
Pathol Int; 2013 Dec; 63(12):599-606. PubMed ID: 24422956
[TBL] [Abstract][Full Text] [Related]
48. Prognostic significance of SOX18 expression in non-small cell lung cancer.
Jethon A; Pula B; Olbromski M; Werynska B; Muszczynska-Bernhard B; Witkiewicz W; Dziegiel P; Podhorska-Okolow M
Int J Oncol; 2015 Jan; 46(1):123-32. PubMed ID: 25310193
[TBL] [Abstract][Full Text] [Related]
49. Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer.
Liang JZ; Li YH; Zhang Y; Wu QN; Wu QL
Int J Clin Exp Pathol; 2015; 8(3):2937-45. PubMed ID: 26045802
[TBL] [Abstract][Full Text] [Related]
50. LRIG1 is a prognostic biomarker in non-small cell lung cancer.
Kvarnbrink S; Karlsson T; Edlund K; Botling J; Lindquist D; Jirström K; Micke P; Henriksson R; Johansson M; Hedman H
Acta Oncol; 2015; 54(8):1113-9. PubMed ID: 25813475
[TBL] [Abstract][Full Text] [Related]
51. Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.
Dalloneau E; Baroukh N; Mavridis K; Maillet A; Gueugnon F; Courty Y; Petit A; Kryza T; Del Rio M; Guyetant S; Cadena Castaneda DC; Dhommée C; Arnoult C; Scorilas A; Gouilleux-Gruart V; Heuzé-Vourc'h N
Oncotarget; 2016 Aug; 7(34):54415-54429. PubMed ID: 27384673
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of TIM-1 expression in human non-small-cell lung cancer.
Zheng X; Xu K; Chen L; Zhou Y; Jiang J
J Transl Med; 2019 May; 17(1):178. PubMed ID: 31138322
[TBL] [Abstract][Full Text] [Related]
53. Correlation of neuroendocrine features with prognosis of non-small cell lung cancer.
Feng J; Sheng H; Zhu C; Qian X; Wan D; Su D; Chen X; Zhu L
Oncotarget; 2016 Nov; 7(44):71727-71736. PubMed ID: 27687592
[TBL] [Abstract][Full Text] [Related]
54. Src kinase-associated phosphoprotein2 expression is associated with poor prognosis in non-small cell lung cancer.
Kuranami S; Yokobori T; Mogi A; Altan B; Yajima T; Onozato R; Azuma Y; Iijima M; Kosaka T; Kuwano H
Anticancer Res; 2015 Apr; 35(4):2411-5. PubMed ID: 25862907
[TBL] [Abstract][Full Text] [Related]
55. High expression of eIF4A2 is associated with a poor prognosis in esophageal squamous cell carcinoma.
Lyu S; Lu J; Chen W; Huang W; Huang H; Xi S; Yan S
Oncol Lett; 2020 Nov; 20(5):177. PubMed ID: 32934744
[TBL] [Abstract][Full Text] [Related]
56. Down Expression of FBP1 Is a Negative Prognostic Factor for Non-Small-Cell Lung Cancer.
Sheng H; Ying L; Zheng L; Zhang D; Zhu C; Wu J; Feng J; Su D
Cancer Invest; 2015 May; 33(5):197-204. PubMed ID: 25844935
[TBL] [Abstract][Full Text] [Related]
57. [Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer:
Analysis Based on the Data-mining of Oncomine].
Ye L; Li H; Zhang F; Lv T; Liu H; Song Y
Zhongguo Fei Ai Za Zhi; 2017 Dec; 20(12):822-826. PubMed ID: 29277180
[TBL] [Abstract][Full Text] [Related]
58. [EFR-like peptides and their receptors as prognostic factors for the survival of patients with non-small-cell lung cancer].
Kostyleva OI; Gerstein ES; Dykhno AIu; Vasil'ev AV; Polotskiĭ BE; Kushlinskiĭ NE
Vopr Onkol; 1999; 45(6):617-22. PubMed ID: 10703508
[TBL] [Abstract][Full Text] [Related]
59. Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung.
Strauss GM; Kwiatkowski DJ; Harpole DH; Lynch TJ; Skarin AT; Sugarbaker DJ
J Clin Oncol; 1995 May; 13(5):1265-79. PubMed ID: 7738631
[TBL] [Abstract][Full Text] [Related]
60. eIF4A2 is a host factor required for efficient HIV-1 replication.
Ndzinu JK; Takeuchi H; Saito H; Yoshida T; Yamaoka S
Microbes Infect; 2018; 20(6):346-352. PubMed ID: 29842983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
